Connect with us
European Gaming Congress 2024

Artificial Intelligence

BioMed Leaders KRBP, NMLSF, VERU, AIMLF Report Latest Advances in Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech AI

Published

on

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Kiromic BioPharma (NASDAQ: KRBP), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Veru Inc. (NASDAQ: VERU) and AI/ML Innovations (OTC: AIMLF) (CSE: AIML). As the global pharma market surpasses $1.3 trillion dollars (Statista), emerging technologies and healthcare research innovations are unleashing new exponential growth opportunities. As the biotech sector rebounds from cyclical lows, institutional investors are increasingly eyeing early-stage biotech stocks for upside potential delivering alpha. Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead:

Kiromic BioPharma (NASDAQ: KRBP) CEO Pietro Bersani: “Gamma Delta T cell Pipeline Expanding to Five”
Kiromic BioPharma (NASDAQ: KRBP), a clinical-stage biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) and data mining platform to discover and develop cell and gene therapies with a focus on immuno-oncology, has entered into a sponsored research agreement with Principal Investigator James W. Welsh, M.D. of The University of Texas MD Anderson Cancer Center.
Under the two-year SRA, in vivo preclinical data will be generated from Kiromic’s Gamma Delta T cell allogeneic therapies. This SRA is intended to evaluate efficacy and patient safety outcomes to support three new investigational drug (IND) applications to the U.S. Food and Drug Administration. KRBP CEO Pietro Bersani commented: “We believe that the SRA will enable us to generate key in vivo data efficiently and swiftly that will demonstrate the synergistic advantages of our Gamma Delta T cell therapies in combination with existing anticancer treatment modalities. These submissions will expand the total number of our product candidate therapies to five. We expect to begin the activation of the Delta T cell clinical trial by the end of this year. We believe utilizing non-genetically engineered Gamma Delta T cells as our first-in-human study is ideal to establish the tolerability and safety of our proprietary allogeneic cell therapy platform.”
Kiromic BioPharma (NASDAQ: KRBP) News: https://www.wallstreetreporter.com/2022/06/07/kiromic-biopharma-nasdaq-krbp-significantly-expands-gamma-delta-t-cell/

AI/ML Innovations (OTC: AIMLF) (CSE: AIML) Chairman, Tim Daniels: “AI/ML Holds Key Patents for Multi-Billion Dollar Healthcare Wearables Market”
AI/ML Innovations (OTC: AIMLF), a featured presenter at Wall Street Reporter’s “Next Super Stock” investor conference series, recently updated investors on growth initiatives at AIMLF’s portfolio of digital health businesses including HealthGauge, a wearable personal health monitoring & management system, using Artificial Intelligence and Machine Learning, and Tech2Heal a European mental health app innovator.

Of significant interest for investors is AIMLF’s landmark patent position for wearable health monitors – which could position AIMLF to collect licensing fees and royalties on the $13.8 Billion global Smart Wearable Healthcare Devices (projected to reach $37.4 Billion by 2028. Source: Verified Market Research). AIMLF is now starting to license its technologies to health wearables companies, and collecting royalties. With typical royalties of 2% of gross sales, AIMLF could potentially generate significant recurring revenues from companies infringing on its broad patent position in the nearly $14 billion health wearables market.
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/

AIMLF’s Health Gauge subsidiary, has recently been granted a patent by the United States Patent and Trademark Office (US Patent No. 11183303), titled “Wearable Health Monitors and Methods of Monitoring Health”. The Patent covers Cardiovascular monitoring, Predictive health analysis, Behavioral analysis and 64 other claims, including use of multiple configurations of wearable health monitors, in conjunction with methods of analyzing bio-signals and monitoring health metrics (via Health Gauge’s AI-driven software) for the purpose of assisting the user in achieving their personal health and wellness objectives.

Advertisement
Stake.com

AIMLF is reporting advancing growth at its portfolio company Tech2Heal, a European mental health app innovator. Tech2Heal is positioned for explosive revenue growth as European healthcare mandates now provide about 2,500 Euro per patient annually for mental wellness. Tech2Heal has just signed with a French multinational manufacturer, to provide mental wellness support to their 170,000 employees globally, and additional Enterprise contracts are in the pipeline. Tim Daniels also updated investors on AIML’s growing pipeline of M&A opportunities in the HealthTech space, which could have a positive impact on maximizing shareholder value in coming months.
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/

Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Promise for Autism and Other Neuroinflammatory Disorders”
Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investor conference is advancing psilocybin-based novel therapeutics, targeting autism spectrum disorders, an unmet medical need with multi-billion dollar market potential. NMLSF Chief Medical Officer Dr. Marvin Hausman, M.D., has a decades-long track record of success advancing new drugs through the FDA regulatory pathways, into commercialization, generating billions of dollars in revenue. Dr. Hausman, is now bringing the “same playbook” to NMLSF for its psilocybin-based therapeutics targeting Fragile X, then potential expansion to treat other neuroinflammatory disorders, including alzheimers, and parkinsons. NMLSF plans to submit a clinical trial application to Health Canada for a Phase 2A study evaluating its psilocybin microdose therapy for Fragile X Syndrome, in the coming weeks.

NMLSF is a global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. NMLSF is the first biotech company to achieve FDA “Orphan Drug Designation” in both the United States and European Union for the use of psilocybin in the treatment of FXS. In his interview, with Wall Street Reporter, Dr. Hausman explains his strategy for advancing NMLSF’s drug pipeline through commercialization, as he has successfully accomplished with other novel drugs during his decades-long career.
Watch NEXT SUPER STOCK Nova Mentis (OTC: NMLSF) (CSE: NOVA) Video: https://www.wallstreetreporter.com/2022/03/25/next-super-stock-nova-mentis-life-sciences-otc-nmlsf-billions-opportunity-w-autism-psilocybin/

“The recently completed preclinical study of repeat low doses of our psilocybin drug – every other day for 2 weeks, showed clinical responses that greatly exceeded our expectations. We significantly modulated behavioural and cognitive defects, such as recognition memory, in FXS.” NMLSF plans to submit a clinical trial application to Health Canada in the coming weeks for a Phase 2A study evaluating psilocybin microdose therapy for FXS. “Autism spectrum disorder (“ASD”) and especially FXS, the largest genetic cause of ASD, continue to have unmet medical needs. Scientists at NOVA, over the past two years, have laid the groundwork for development of potential novel psilocybin-based microdose treatment of ASD,” said NMLSF Chief Medical Officer, Dr. Marvin S. Hausman, MD.
Watch NEXT SUPER STOCK Nova Mentis (OTC: NMLSF) (CSE: NOVA) Video: https://www.wallstreetreporter.com/2022/03/25/next-super-stock-nova-mentis-life-sciences-otc-nmlsf-billions-opportunity-w-autism-psilocybin/

Veru Inc. (NASDAQ: VERU) CEO Mitchell Steiner, M.D: “Sabizabulin Delivers Significant Milestone in COVID-19”
Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company, today announced positive efficacy and safety results from a planned interim analysis of the double-blind, randomized, placebo-controlled Phase 3 COVID-19 clinical trial evaluating oral sabizabulin 9 mg versus placebo in 150 hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS). The Independent Data Safety Monitoring Committee unanimously recommended that the Phase 3 study be halted early due to efficacy, and they further remarked that no safety concerns were identified.
CEO Mitchell Steiner, M.D, commented: “This study represents a significant milestone in the global fight against COVID-19 as sabizabulin is the first drug to demonstrate a clinically and statistically meaningful reduction in deaths in hospitalized patients with moderate to severe COVID-19. We strongly believe that sabizabulin, with its dual anti-viral and anti-inflammatory properties which demonstrated positive efficacy and safety results in the Phase 3 COVID-19 study, can be that greatly needed oral therapy for hospitalized moderate to severe COVID-19 patients.”
Veru Inc. (NASDAQ: VERU) News: https://www.wallstreetreporter.com/2022/04/11/verus-novel-covid-19-drug-candidate-reduces-deaths-by-55/

Advertisement
Stake.com

WALL STREET REPORTER

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: https://tinyurl.com/2x4eznd5

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

CONTACT:

Advertisement
Stake.com

WALL STREET REPORTER

(212) 871-2057 ext 7

www.WallStreetReporter.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

YES Delivers Multiple VeroTherm Formic Acid Reflow Systems To Leading Semiconductor Device Customers

Published

on

yes-delivers-multiple-verotherm-formic-acid-reflow-systems-to-leading-semiconductor-device-customers

FREMONT, Calif., June 26, 2024 /PRNewswire/ — YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging applications, today announced that it has delivered multiple VeroTherm Formic Acid Reflow (FAR) systems to leading logic and memory customers. This system will be utilized to enable 3D stacking of memory and logic chips required to support the growth of high-performance AI accelerators driven by large language model (LLM) applications.

The VeroTherm FAR system is designed to provide solutions for achieving sub 10-micron micro-bump structures with fluxless solder and mass reflow processes. This system enables superior quality and total cost of ownership (CoO) particularly for the manufacturing of advanced packaging architectures such stacked logic and high bandwidth memory (HBM) that are an integral part of the AI accelerators currently being launched in the market.
“The VeroTherm offers unique single wafer chamber design with flexibility to improve reflow quality and addresses challenges associated with reduced bump pitches. YES has demonstrated superior reflow results with no bump cracking defects observed at sub-30 micron pitch and no collapsed bumps with pitches down to 12um. YES proprietary process also results in defect-free solder reflow resulting in high throughput and low CoO. These results can extend bump-based mass reflow technology to sub-10um pitch,” said Alex Chow, SVP Global Sales at YES. “These orders are an important milestone for YES as it is a validation of our efforts to serve the multiple market segments,” Chow added.
According to Saket Chadda, SVP and GM, Dry Business Unit at YES, “Our Verotherm FAR wafer product line offers vacuum based single wafer processing with unique capabilities of performing the task of removing oxides and reflowing solder into excellent bump shapes without defects found in older atmospheric pressure systems. It eliminates SnAg agglomerate defects and rough surfaces while minimizing inter-metallic compound zones with extendibility down to sub-10um micron pitches.”
About YES
YES (Yield Engineering Systems, Inc.) is a leading manufacturer of high-tech, cost-effective equipment for transforming surfaces, materials and interfaces.  The company’s product lines include vacuum cure ovens, chemical vapor deposition (CVD) systems, and plasma etching tools used for precise surface modification and thin-film coating of semiconductor wafers, semiconductor and MEMS devices, and biodevices. With YES, customers ranging from startups to Fortune 100 companies can create and volume-produce products in a wide range of markets, including Advanced Packaging, MEMS, Augmented Reality/Virtual Reality and Life Sciences. YES is headquartered in Fremont, California, with a growing global presence. For more information, please visit www.yieldengineering.com.
Media Contact
Alex ChowSVP Business Development & Mktg / Asia PresidentYES (Yield Engineering Systems, Inc.)+886-926136155 [email protected] 
Logo – https://mma.prnewswire.com/media/2357724/YES_TM_logo_RGBv2_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/yes-delivers-multiple-verotherm-formic-acid-reflow-systems-to-leading-semiconductor-device-customers-302182191.html

Continue Reading

Artificial Intelligence

Amagi Strengthens its European Presence With the Inauguration of a New Office in Poland

Published

on

amagi-strengthens-its-european-presence-with-the-inauguration-of-a-new-office-in-poland

Amagi to Develop Flagship LIVE Products at Central European Innovation Center
ŁÓDŹ, Poland, June 26, 2024 /PRNewswire/ — Amagi, a leading global provider of cloud-based SaaS technology for broadcast and Connected TV (CTV), is focusing on engaging with the vibrant young technology talent in Poland as it inaugurates a new office in the bustling center of Łódź. This move underlines Amagi’s dedication to harnessing the exceptional technology skills found in Poland, aiming to shape the future of global media and entertainment.

Poland has strategically positioned itself as a magnet for tech innovation. Its robust educational system produces engineering, computer science, and other tech-related graduates. This abundance of skilled professionals and a supportive environment make Poland a prime location for companies looking to tap into the global tech scene.
“The inauguration of this innovation center in Central Europe marks a key milestone in Amagi’s journey,” says Baskar Subramanian, Co-Founder and CEO of Amagi. “This center will provide a platform for Polish technology professionals to serve our global customers, underscoring Amagi’s strategic vision of being a frontrunner in the cloud-based live broadcast technology domain.”  
“The entry of Amagi into our market is a significant event for our technology sector,” says Adam Pustelnik, First Deputy Mayor of the City of Łódź. “This industry is growing rapidly and constantly needs new solutions, specialists, and a specific talent pool. We are delighted to collaborate with such an innovative company and support the development of our City together. I believe that Amagi, as a strong global brand, will help strengthen Łódź’s position in the global media technology market.”
In 2023, Amagi expanded its global footprint by acquiring Tellyo, a Polish company specializing in broadcast technology solutions. This strategic move marked Amagi’s initial foray into the Polish market and proved to be a significant growth catalyst for the company.  The talented Polish development teams are now at the forefront of several of Amagi’s industry-leading products, including Tellyo STUDIO, a platform designed to streamline live content production and delivery, and Tellyo PRO, a suite of tools tailored explicitly for high-pressure live broadcast environments like elections and significant sporting events, such as the Olympics.
“At Amagi, we’re driven by four core values that empower everyone in our ecosystem, from employees to customers, to thrive and reach their full potential truly,” says Prasad Menon, Chief People Officer at Amagi. “Our Polish team perfectly embodies this philosophy.  Their exceptional talent, dedication, and deep understanding of technology fuel the development of our industry-leading solutions.  Their ability to deliver cutting-edge products like Tellyo Studio and Tellyo Pro ensures Amagi continues to meet the ever-changing needs of the global media landscape.”
Amagi has significantly increased its customer base in the European region. It now delivers services to large media and entertainment industry players like DAZN, Grupa Polsat-Interia, and many more. Amagi also delivers linear channels in over 40 countries worldwide, with a strong presence in the American market. Its global client list includes ABS-CBN, AccuWeather, A+E Networks UK, Cineverse, and more.
About Amagi
Amagi is a next-generation media technology company that provides cloud broadcast and targeted advertising solutions to broadcast TV and streaming TV platforms. Amagi enables content owners to launch, distribute, and monetize live linear channels on Free Ad-supported Streaming TV and video services platforms. Amagi also offers 24×7 cloud-managed services bringing simplicity, advanced automation, and transparency to the entire broadcast operations. Overall, Amagi supports 800+ content brands, 800+ playout chains, and over 3800+ channel deliveries on its platform in over 150 countries. Amagi has a presence in New York, Los Angeles, London, Paris, Melbourne, Seoul, Singapore, and broadcast operations in New Delhi, and innovation centers in Bangalore, Zagreb, and Łódź.
About Invest in Łódź 
Our Bureau supports investors & businesses by being an integrator of diverse entities around the City and its offerings and facilitating relations among stakeholders. Moreover we provide services and tools that create value for future investors and stakeholders and promote the business brand of the City.
Link to Word Doc: www.wallstcom.com/Amagi/240625-Amagi-Poland.docx 
Link to Polish Translation: www.wallstcom.com/Amagi/240625-Amagi-Poland-Po.docx
Photo Link: www.wallstcom.com/Amagi/Poland_Office.jpg
Photo Caption: Deputy Mayor of the City of Łódź, Adam Pustelnik, Prasad Menon, Chief People Officer at Amagi, Mariusz OstojaSwierczynski, Senior Director of Engineering at Amagi, and Jakub Majkowski, Founder and COO of Tellyo, at the inauguration of the new innovation center in Łódź.
 
Amagi Contact:
Aashish Washikar
Director – Corporate Communications
Email: [email protected]
Phone : +91 9533390005

Photo – https://mma.prnewswire.com/media/2447827/Amagi_New_Office.jpg

View original content:https://www.prnewswire.co.uk/news-releases/amagi-strengthens-its-european-presence-with-the-inauguration-of-a-new-office-in-poland-302182268.html

Continue Reading

Artificial Intelligence

Synechron to acquire Adelaide-headquartered companies Chamonix IT and Exposé to grow its digital transformation, engineering, AI, and data and analytics capabilities in Australia

Published

on

synechron-to-acquire-adelaide-headquartered-companies-chamonix-it-and-expose-to-grow-its-digital-transformation,-engineering,-ai,-and-data-and-analytics-capabilities-in-australia

This acquisition extends Synechron’s reach across the country, establishing a presence in key hubs and unlocking new industries and clients.
SYDNEY and NEW YORK and LONDON and PUNE, India, June 26, 2024 /PRNewswire/ — Synechron, a global leader in digital transformation consulting for the financial and technology sectors, is proud to announce that it has executed a definitive agreement for the acquisition of Chamonix IT Management Consulting Pty Ltd and Exposé Data Pty Ltd. Both companies are headquartered in Adelaide, Australia, with additional operations in Melbourne and Brisbane and share a common goal of delivering digital transformation, artificial intelligence, and analytics expertise to clients across several key industries including government, healthcare, utilities, energy, and education. The definitive agreement with respect to the acquisition was signed on Tuesday, 25 June, 2024, and is subject to customary closing conditions, including approval by the Australian Foreign Investment Review Board (FIRB).

Chamonix IT, established in 2010, is the leading provider of digital transformation services to organizations in South Australia. With a skilled team of approximately 150 professionals, Chamonix IT has been pivotal in delivering cutting-edge solutions that address complex challenges and drive significant outcomes for enterprise-level and public sector clients. Chamonix IT’s founders established Exposé as a new company in 2016 to bring the same level of expertise, this time focused specifically on data science and engineering, data modelling and visualization, and artificial intelligence. Among the fastest-growing IT organizations in Australia, Exposé currently has a team of approximately 50 people across the country.
The two organizations will join Synechron’s core digital transformation consulting business alongside recently acquired iGreenData, which expanded Synechron’s data and blockchain expertise in the financial services sector. With these additions, Synechron has effectively doubled its presence in the country, achieving coverage across major sectors. This strategic positioning allows the company to capitalize on the growing information technology (IT) investment in Australia encompassing SaaS, IT services, and analytics, while simultaneously enhancing its ability to offer support and solutions across Asia, the Americas, and Europe.
Faisal Husain, Synechron Co-founder and CEO, commented, “We look forward to welcoming Chamonix IT and Exposé into the Synechron family when the acquisition is completed. They will enrich our presence in Australia, bringing fresh expertise and capabilities that complement our ongoing commitment in the region. This move will enhance our service offerings and drive significant value, strengthening our strategy of continuous innovation and client-focused solutions.”
Scott Grigg, CEO of Chamonix IT, said, “Joining forces with Synechron is a significant milestone for us. Our shared dedication to excellence and innovation means we’re exceptionally positioned to offer transformative digital solutions that are second to none.”
Kelly Drewett, CEO of Exposé, added, “Becoming part of the Synechron family represents a massive opportunity. It accelerates our ability to innovate and empowers our employees to take on even more complex challenges on behalf of our clients.”
Technology Holdings acted as the financial advisor to Chamonix IT and Exposé on the transaction.
About Synechron:
At Synechron, we believe in the power of digital to transform businesses for the better. Our global consulting firm combines creativity and innovative technology to deliver industry-leading digital solutions. Synechron’s progressive technologies and optimization strategies span end-to-end Artificial Intelligence, Consulting, Digital, Cloud & DevOps, Data, and Software Engineering, servicing an array of noteworthy financial services and technology firms. Through research and development initiatives in our FinLabs we develop solutions for modernization, from Artificial Intelligence and Blockchain to Data Science models, Digital Underwriting, mobile-first applications and more. Over the last 20+ years, our company has been honored with multiple employer awards, recognizing our commitment to our talented teams. With top clients to boast about, Synechron has a global workforce of 14,000+, and has 55 offices in 20 countries within key global markets. For more information on the company, please visit our website or LinkedIn community.
About Chamonix IT:
Chamonix IT empowers businesses to excel through transformative IT services. Serving both enterprise and government organizations, Chamonix IT delivers tailored solutions that ensure long-term success. Chamonix IT’s expertise spans Advisory, Cloud & Infrastructure, Application Innovation, Security, and Managed Services, enabling businesses to remain competitive and innovative in an ever-evolving landscape. By embracing an adaptable and flexible approach, Chamonix IT helps organizations navigate the complexities of digital transformation to propel their business forward.
About Exposé:
Exposé is a leading data analytics and AI consulting firm delivering data-driven insights and business-focused outcomes to private and public sector clients across Australia. Exposé’s approach is designed to give its clients the quickest and most cost-effective path to tackle data and AI opportunities through best practice. Clients benefit from Exposé’s significant experience, research and development, and innovation, which is at the core of what we do and the values we uphold. Founded in 2016, Exposé is now the largest data analytics and AI business in South Australia and one of only a few female-led technology businesses in the region.
For more information please contact:
Rashmi Joshi,[email protected] [email protected]
OR
 Zoe Forbes-Pyfrom (+44) 7718 [email protected]
Logo: https://mma.prnewswire.com/media/1943591/Synechron_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/synechron-to-acquire-adelaide-headquartered-companies-chamonix-it-and-expose-to-grow-its-digital-transformation-engineering-ai-and-data-and-analytics-capabilities-in-australia-302181486.html

Continue Reading

Trending